| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 543 |
| 1 | ETANERCEPT | 469 |
| 2 | UPADACITINIB | 344 |
| 3 | METHOTREXATE SODIUM | 306 |
| 4 | METHOTREXATE | 292 |
| 5 | RISANKIZUMAB-RZAA | 210 |
| 6 | TOFACITINIB | 207 |
| 7 | PREDNISONE | 190 |
| 8 | ABATACEPT | 183 |
| 9 | GABAPENTIN | 169 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BISMUTH SUBGALLATE | 1 | 0.0217 |
| 1 | HALOBETASOL PROPIONATE AND TAZAROTENE | 2 | 0.0101 |
| 2 | INFLIXIMAB-DYYB | 28 | 0.0081 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 18 | 0.0065 |
| 4 | BUROSUMAB | 41 | 0.0063 |
| 5 | GOLIMUMAB | 79 | 0.0063 |
| 6 | ERGOCALCIFEROL | 166 | 0.0056 |
| 7 | AMLODIPINE AND VALSARTAN | 1 | 0.0051 |
| 8 | AURANOFIN | 1 | 0.0049 |
| 9 | MEXILETINE HYDROCHLORIDE | 2 | 0.0048 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 770 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 406 |
| 2 | Janus Kinase Inhibitor [EPC] | 352 |
| 3 | Corticosteroid [EPC] | 303 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 287 |
| 5 | Interleukin-23 Antagonist [EPC] | 244 |
| 6 | Vitamin C [EPC] | 188 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 183 |
| 8 | Benzodiazepine [EPC] | 167 |
| 9 | Proton Pump Inhibitor [EPC] | 167 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 26 | 0.0378 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 18 | 0.0087 |
| 2 | Provitamin D2 Compound [EPC] | 166 | 0.0056 |
| 3 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |
| 4 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 19 | 0.0027 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 33 | 0.0025 |
| 6 | PCSK9 Inhibitor [EPC] | 63 | 0.0024 |
| 7 | Interleukin-23 Antagonist [EPC] | 244 | 0.0023 |
| 8 | Janus Kinase Inhibitor [EPC] | 352 | 0.0022 |
| 9 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |